Guatemala

The Global Fund Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments, and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.The 2020-2021 Annual Report presents findings from the grant cycle analysis which examined what, when, why, and how grants approved through the New Funding Model 2 (NFM2; 2017-2019 funding cycle) changed over time, including significant factors that influenced the implementation of changes to the original grant. Additionally, the report includes findings on how the NFM3 (2020-2022 funding cycle) grant design process was informed by lessons from NFM2.The 2021 Extension Phase Report presents findings from a three-month extension of the PCE that focused on a deeper analysis of several areas within the grant cycle analysis, including: grant revision and lessons learnt from the Global Fund’s response to COVID-19, investments in health systems support and health systems strengthening, uptake of new RSSH coverage indicators, and drivers of budgetary shifts in RSSH and equity-related investments during NFM3 grant making.

The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments, and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings synthesized across the eight PCE countries in 2020 presenting a comprehensive look at the Global Fund grant cycle. The PCE assessed how business model factors have facilitated or hindered the achievement of objectives during implementation of grants approved during the 2017-19 funding cycle, including around Resilient and Sustainable Systems for Health (RSSH), sustainability and equity, and whether lessons learned during current grants have informed the next funding cycle. The objective of this grant cycle analysis was to understand what, when, why, and how grant investments change over time, including significant factors that influenced the implementation of and changes to the original grant.

This brief summarizes the experience and capabilities of the PATH Cervical Cancer Team. For decades, PATH has been at the forefront of evidence-based strategies from HPV vaccine research and delivery to cervical cancer screening and treatment to ensure we best meet the needs and realities of these countries for the greatest health impact.

The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings from Guatemala in 2019-2020.

Una hoja informativa que proporciona una descripción general de la Herramienta de Planificación para el Precáncer Cérvicouterino, incluidos los antecedentes, una descripción general de los escenarios y cómo la herramienta puede apoyar la planificación basada en evidencia.

Un modelo interactivo de Excel que evalúa las ventajas y desventajas de cuatro estrategias del tamizaje del cáncer cérvicouterino y cinco escenarios de tratamiento del precáncer cérvicouterino, al analizar la cantidad de mujeres alcanzadas, la eficacia del enfoque y los costos asociados. Haga clic en el enlace arriba para descargar el archivo Excel. CONSULTE LA NOTA ACLARATORIA EN LA HERRAMIENTA ANTES DE USAR.

A fact sheet that provides an overview of the Cervical Precancer Planning Tool, including the background, a scenario overview, and how the tool can support evidence-based planning.

An interactive Excel model that evaluates the trade-offs of four cervical cancer screening approaches and five cervical precancer treatment scenarios, looking at number of women reached, effectiveness of approach, and associated costs. Click the above link to download the Excel file. SEE DISCLAIMER IN TOOL BEFORE USE.

The Prospective Country Evaluation (PCE) is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments, and contribution to disease program outcomes and impact in eight countries. The PCE generates timely evidence to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.This report presents findings synthesized across the eight PCE countries in 2019 with a focus on evaluating progress and analyzing impact of grants funded through the 2017-2019 allocation and implemented during 2018-2019. Findings were structured around three out of the four Global Fund strategic objectives (SOs): grant implementation and contribution to disease impact (SO1); grant contribution to national Resilient and Sustainable Systems for Health outcomes (SO2); and grant contribution to national program key population, human rights, and gender-related outcomes (SO3).

La Evaluación Prospectiva de País es una plataforma de evaluación que incorpora métodos mixtos diseñada para examinar el modelo de negocios del Fondo Mundial, sus inversiones y contribuciones para que los programas nacionales de VIH, tuberculosis y malaria tengan resultados positivos e impacto. La EPP se lleva a cabo en ocho países y genera evidencia oportuna para promover mejoras en losprogramas y acelerar el progreso hacia los objetivos estratégicos del Fondo Mundial 2017-2022.Este resumen presenta los resultados de Guatemala, así como los resultados sintetizados en los ocho países EPP en 2018.